» Articles » PMID: 30783377

The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions

Overview
Publisher Sage Publications
Date 2019 Feb 21
PMID 30783377
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A major reason for biomarker failure is the selection of candidate biomarkers based on inaccurate or incorrect published results. Incorrect research results leading to the selection of unproductive biomarker candidates are largely considered to stem from unintentional research errors. The additional possibility that biomarker research may be actively misdirected by research fraud has been given comparatively little consideration. This review discusses what we believe to be a new threat to biomarker research, namely, the possible systematic production of fraudulent gene knockdown studies that target under-studied human genes. We describe how fraudulent papers may be produced in series by paper mills using what we have described as a 'theme and variations' model, which could also be considered a form of salami slicing. We describe features of these single-gene knockdown publications that may allow them to evade detection by journal editors, peer reviewers, and readers. We then propose a number of approaches to facilitate their detection, including improved awareness of the features of publications constructed in series, broader requirements to post submitted manuscripts to preprint servers, and the use of semi-automated literature screening tools. These approaches may collectively improve the detection of fraudulent studies that might otherwise impede future biomarker research.

Citing Articles

An extra pair of eyes: adopting innovative approaches to detect integrity issues in Naunyn-Schmiedeberg's Archives of Pharmacology.

van Diest R, Seifert R, van der Heyden M Naunyn Schmiedebergs Arch Pharmacol. 2025; 398(1):1-8.

PMID: 39751822 PMC: 11787271. DOI: 10.1007/s00210-024-03697-1.


A call for research to address the threat of paper mills.

Byrne J, Abalkina A, Akinduro-Aje O, Christopher J, Eaton S, Joshi N PLoS Biol. 2024; 22(11):e3002931.

PMID: 39576835 PMC: 11602203. DOI: 10.1371/journal.pbio.3002931.


The landscape of biomedical research.

Gonzalez-Marquez R, Schmidt L, Schmidt B, Berens P, Kobak D Patterns (N Y). 2024; 5(6):100968.

PMID: 39005482 PMC: 11240179. DOI: 10.1016/j.patter.2024.100968.


How to fight fake papers: a review on important information sources and steps towards solution of the problem.

Wittau J, Seifert R Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9281-9294.

PMID: 38970685 PMC: 11582211. DOI: 10.1007/s00210-024-03272-8.


Large-scale falsification of research papers risks public trust in biomedical sciences.

Bricker-Anthony R, Herzog R Mol Ther. 2024; 32(4):865-866.

PMID: 38503297 PMC: 11163214. DOI: 10.1016/j.ymthe.2024.03.015.


References
1.
Huang W, Huang H, Wang L, Hu J, Song W . SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma. Onco Targets Ther. 2017; 10:2825-2833. PMC: 5476752. DOI: 10.2147/OTT.S79727. View

2.
Kern S . Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res. 2012; 72(23):6097-101. PMC: 3513583. DOI: 10.1158/0008-5472.CAN-12-3232. View

3.
Nourse C, Mattei M, Gunning P, Byrne J . Cloning of a third member of the D52 gene family indicates alternative coding sequence usage in D52-like transcripts. Biochim Biophys Acta. 1998; 1443(1-2):155-68. DOI: 10.1016/s0167-4781(98)00211-5. View

4.
Jackson D, Walter G, Daly J, Cleary M . Editorial: multiple outputs from single studies: acceptable division of findings vs. 'salami' slicing. J Clin Nurs. 2013; 23(1-2):1-2. DOI: 10.1111/jocn.12439. View

5.
Ma X, Yan J, Chen W, Du P, Xie J, Yu H . Knockdown of Myosin VI Inhibits Proliferation of Hepatocellular Carcinoma Cells In Vitro. Chem Biol Drug Des. 2015; 86(4):723-30. DOI: 10.1111/cbdd.12544. View